This learning plan, based on IRIS Registry measure IRIS45: Exudative Age-Related Macular Degeneration: Loss of Visual Acuity, reviews the impact of anti-VEGF injections in patients with wet age-related macular degeneration (AMD), including genetic predictive biomarkers of anti-VEGF treatment responses.

Funded in part by the Retina Research Foundation